ArticleNeoplasia (New York, N.Y.)2017

Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer.

Frank Jacobsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.